Claris Lifesciences Limited Q1, Q2, Q3, Q4, FY 2016-17, FY 2015-16 Standalone / Consolidated Results, Revenues, Net Profit, Tax, EPS, Live Chart …

Claris Lifesciences Limited Company Profile :

Claris Lifesciences Limited is an Indian company engaged in manufacturing of drugs and pharmaceuticals products.

The Company through its subsidiaries manufactures and markets products, including anesthesia, blood products, anti-infective and plasma volume expanders and offers intravenous nutrition products. The Company’s product range includes therapeutic segments, including infusion therapy and parenteral nutrition. The products are offered through various delivery systems, such as glass and plastic bottles (EURO Head & Nipple Head), ampoules, and non-polyvinyl chloride (PVC)/PVC bags.

The Company’s subsidiaries include Claris Lifesciences Venezuela C.A., Catalys Venture Cap Limited, Claris Pharmaservices and Claris SteriOne.


Claris Lifesciences ResultsBSE Code : 533288
NSE Symbol :
ISIN No. : INE562G01018
Industry : Pharmaceuticals
Face Value : Rs. 10.00


If you are an investor who has shares of Claris Lifesciences or you are an stock market analyst then i am sure you might for Quarterly Results of Claris Lifesciences.

In this article you will find Q1, Q2, Q3, Q4 and FY 2016-17 Results of Claris Lifesciences. That’s not all, you can compare those results with previous year i.e., FY 2015-16 Results of Claris Lifesciences.

Claris Lifesciences Q1 Results 2016-17 :

Claris Lifesciences will announce its Q1 FY 2016-17 Results in the month of July 2016. We will update the table below once the results are announced.

(Values in Cr.) Q1 Standalone Q1 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Claris Lifesciences will announce its Q2 FY 2016-17 Results in the month of October 2016.

(Values in Cr.) Q2 Standalone Q2 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Claris Lifesciences will announce its Q3 FY 2016-17 Results in the month of January 2017.

(Values in Cr.) Q3 Standalone Q3 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Claris Lifesciences will announce its Q4 FY 2016-17 Results in the month of April 2017.

(Values in Cr.) Q4 Standalone Q4 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Claris Lifesciences will announce its FY 2016-17 Results in the month of April 2017.

(Values in Cr.) FY 2016-17 Standalone FY 2016-17 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Note : We will update the results table above as and when results are announced. Visit again.

Claris Lifesciences Previous Year’s Results (FY 2015-16) :

(Values in Cr.) Standalone Consolidated
Revenue  547.22 754.21
Other Income  40.97 40.46
Total Income  588.18 794.67
Expenditure  -538.18 -651.57
Interest  -3.87 -42.77
Depreciation  -6.11 -42.91
PBT  39.29 100.33
Tax  -7.86 -28.42
Net Profit  -6.41 34.07
Equity  54.57 54.57
EPS  -1.17 -10.64

Note : If you like this information about Claris Lifesciences Quarterly Results, then please share it with all your friends, relatives and other investors on Facebook, Twitter, WhatsApp, Email, etc.